Cyclin-dependent kinase 4, encoded by CDK4, might play key roles in the tumorigenesis (Wang et al., 2017) of a variety of cancers through deregulation of the CDK4/6–cyclin D–INK4–RB pathway (Graf et al., 2010). This evidence concerns the gene RB1 and cancer.